Report Categories Report Categories

Report Categories

industry Category

All

Total: 4 records, 1 pages

Global Plasma-derived Therapies Supply, Demand and Key Producers, 2024-2030

date 17 Oct 2024

date New Technology

new_biaoQian Plasma-derived Therapies

Plasma-derived Therapies: These are medicinal products that are manufactured from human plasma, the liquid component of blood. Plasma contains important proteins, clotting factors, and antibodies that can be processed and concentrated to create products used in various medical treatments. PDPs are essential for treating conditions such as hemophilia, immune deficiencies, and certain autoimmune diseases.

USD4480.00

Add To Cart

Add To Cart

Global Plasma-derived Therapies Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 17 Oct 2024

date New Technology

new_biaoQian Plasma-derived Therapies

Plasma-derived Therapies: These are medicinal products that are manufactured from human plasma, the liquid component of blood. Plasma contains important proteins, clotting factors, and antibodies that can be processed and concentrated to create products used in various medical treatments. PDPs are essential for treating conditions such as hemophilia, immune deficiencies, and certain autoimmune diseases.

USD3480.00

Add To Cart

Add To Cart

Global Plasma-derived Therapies Supply, Demand and Key Producers, 2023-2029

date 26 Aug 2023

date New Technology

new_biaoQian Plasma-derived Therapies

The global Plasma-derived Therapies market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

Global Plasma-derived Therapies Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 26 Aug 2023

date New Technology

new_biaoQian Plasma-derived Therapies

According to our latest research, the global Plasma-derived Therapies market size will reach USD million in 2029, growing at a CAGR of % over the analysis period.

USD3480.00

Add To Cart

Add To Cart

industry 17 Oct 2024

industry New Technology

new_biaoQian Plasma-derived Therapies

Plasma-derived Therapies: These are medicinal products that are manufactured from human plasma, the liquid component of blood. Plasma contains important proteins, clotting factors, and antibodies that can be processed and concentrated to create products used in various medical treatments. PDPs are essential for treating conditions such as hemophilia, immune deficiencies, and certain autoimmune diseases.

USD4480.00

addToCart

Add To Cart

industry 17 Oct 2024

industry New Technology

new_biaoQian Plasma-derived Therapies

Plasma-derived Therapies: These are medicinal products that are manufactured from human plasma, the liquid component of blood. Plasma contains important proteins, clotting factors, and antibodies that can be processed and concentrated to create products used in various medical treatments. PDPs are essential for treating conditions such as hemophilia, immune deficiencies, and certain autoimmune diseases.

USD3480.00

addToCart

Add To Cart

industry 26 Aug 2023

industry New Technology

new_biaoQian Plasma-derived Therapies

The global Plasma-derived Therapies market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart

industry 26 Aug 2023

industry New Technology

new_biaoQian Plasma-derived Therapies

According to our latest research, the global Plasma-derived Therapies market size will reach USD million in 2029, growing at a CAGR of % over the analysis period.

USD3480.00

addToCart

Add To Cart